MedPath
NMPA Approval

Pertuzumab Injection

国药准字S20240054

December 17, 2024

Drug Information

帕妥珠单抗注射液

帕乐坦

注射剂

420mg(14ml)/瓶

生物制品

December 17, 2024

Company Information

Applicant Company

南京市江宁区福英路1099号(江宁高新园)

Manufacturing Company

南京市江宁区福英路1099号(江宁高新园)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

帕妥珠单抗注射液 - NMPA 批准文号 | MedPath